Certified by Founder Lodge
Lilly Asia Ventures 礼来亚洲基金
China - Shanghai
INVESTOR
1 Disclosed Funding Rounds $200,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
N/A
| Company | Date | Round | Raised |
|---|---|---|---|
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
 Lynk Pharmaceuticals |
September, 22 ,2023 | Series C | |
 Akura Medical |
October, 04 ,2023 | Series B | $35,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
InCharge Energy | $46,000,000 | (Jun 5, 2026)
Forage | $40,000,000 | (Jun 5, 2026)
ZutaCore | $100,000,000 | (Jun 5, 2026)
Quobly | $133,545,475 | (Jun 5, 2026)
Oak Hill Bio | $32,500,000 | (Jun 5, 2026)
